Lactated Ringer's Solution to Prevent Post-ERCP Pancreatitis

Status Not yet recruiting

Clinical Trial Summary

This is a randomized, double-blinded, controlled trial. This study is a head to head comparison of normal saline (NS) infusion versus Lactated Ringer's (LR) infusion in patients, with the primary outcome of post-ERCP pancreatitis occurrence. Patients will be randomized to either the NS infusion group or the LR infusion group. IVF will be started pre-procedurally and will be continued throughout the procedure. A IVF bolus will be given at the end of the procedure and then continued as a continuous infusion. Our null hypothesis is that there will be no significant difference in the rate of occurrence of post-ERCP pancreatitis between the infusion of LR and NS solutions. Our alternative hypothesis is that patients receiving LR solution infusion will experience a decreased rate of post-ERCP pancreatitis compared to patients receiving NS solution infusion.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03215862
Study type	Interventional
Source	University of South Florida
Contact	Primary Investigator
Phone	8139743980
Email	ptaunk@health.usf.edu
Status	Not yet recruiting
Phase	N/A
Start date	August 1, 2017
Completion date	August 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04546867` - Establishing a Sonographic Based Algorithm to Verify Pancreatic Stent Position Placed to Prevent Post-ERCP Pancreatitis Before Endoscopic Removal	N/A
Terminated	`NCT02241512` - IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis	Phase 2
Completed	`NCT00222092` - Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers	Phase 4
Completed	`NCT05310409` - PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
Not yet recruiting	`NCT06260878` - Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis	Phase 4
Not yet recruiting	`NCT04770857` - Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis
Completed	`NCT02641561` - Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis	Phase 3
Active, not recruiting	`NCT04145336` - 7 cm vs. 5 cm Pancreatic Stents for the Prevention of Post-ERCP Pancreatitis in High-risk Patients	N/A
Completed	`NCT03629600` - Trial of Aggressive Hydration Versus Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis	Phase 2/Phase 3
Recruiting	`NCT03756116` - Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide	N/A
Recruiting	`NCT05664074` - Rectal Indomethacin vs Intravenous Ketorolac	Phase 4
Completed	`NCT02308891` - A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis	N/A
Recruiting	`NCT05336630` - Study of Forceps Cannulation During ERCP	N/A
Recruiting	`NCT05857514` - Randomized Controlled Trial of Rectal Indomethacin Versus Combined Pancreatic Stent Placement and Rectal Indomethacin for Preventing Post-ERCP Pancreatitis	N/A
Recruiting	`NCT05267379` - An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis
Recruiting	`NCT05947461` - Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac	N/A
Completed	`NCT03098082` - Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis	N/A
Recruiting	`NCT02830984` - ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP	N/A
Recruiting	`NCT02839356` - Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis	Phase 4
Completed	`NCT01673763` - Post-ERCP Pancreatitis Prevention by Stent Insertion	N/A